Piribedil

Chemical formula: C₁₆H₁₈N₄O₂  Molecular mass: 298.346 g/mol  PubChem compound: 4850

Therapeutic indications

Piribedil is indicated for:

Parkinson's disease

Population group: only adults (18 years old or older)

Treatment of Parkinson’s disease combined with dopatherapy from the onset, or secondarily.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Parkinson's disease

Population group: only adults (18 years old or older)

Parkinson's disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Piribedil is contraindicated in the following cases:

Cardiovascular shock

Cardiogenic shock

Acute phase of myocardial infarction

Acute myocardial infarction

Pulmonary edema

Pulmonary edema

Neuroleptics

Neuroleptics, in tardive dyskinesia

Pregnancy

Pregnancy

Lactation

Lactation

Effects on ability to drive and use machines

Effects on ability to drive and use machines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2013: TRIVASTAL Sustained release coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈